1. Lactobacillus gallinarummodulates the gut microbiota and produces anti-cancer metabolites to protect against colorectal tumourigenesis
- Author
-
Naoki Sugimura, Qing Li, Eagle Siu Hong Chu, Harry Cheuk Hay Lau, Winnie Fong, Weixin Liu, Cong Liang, Geicho Nakatsu, Anthony Chin Yang Su, Olabisi Oluwabukola Coker, William Ka Kei Wu, Francis Ka Leung Chan, and Jun Yu
- Subjects
Gastroenterology - Abstract
ObjectiveUsing faecal shotgun metagenomic sequencing, we identified the depletion ofLactobacillus gallinarumin patients with colorectal cancer (CRC). We aimed to determine the potential antitumourigenic role ofL. gallinarumin colorectal tumourigenesis.DesignThe tumor-suppressive effect ofL. gallinarumwas assessed in murine models of CRC. CRC cell lines and organoids derived from patients with CRC were cultured withL. gallinarumorEscherichia coliMG1655 culture-supernatant to evaluate cell proliferation, apoptosis and cell cycle distribution. Gut microbiota was assessed by 16S ribosomal DNA sequencing. Antitumour molecule produced fromL. gallinarumwas identified by liquid chromatography mass spectrometry (LC-MS/MS) and targeted mass spectrometry.ResultsL. gallinarumsignificantly reduced intestinal tumour number and size compared withE. coliMG1655 and phosphate-buffered saline in both male and female murine intestinal tumourigenesis models. Faecal microbial profiling revealed enrichment of probiotics and depletion of pathogenic bacteria inL. gallinarum-treated mice. Culturing CRC cells withL. gallinarumculture-supernatant (5%, 10% and 20%) concentration-dependently suppressed cell proliferation and colony formation.L. gallinarumculture-supernatant significantly promoted apoptosis in CRC cells and patient-derived CRC organoids, but not in normal colon epithelial cells. OnlyL. gallinarumculture-supernatant with fraction size L. gallinarumculture-supernatant and the gut ofL. gallinarum-treated mice. ILA displayed anti-CRC growthin vitroand inhibited intestinal tumourigenesisin vivo.ConclusionL. gallinarumprotects against intestinal tumourigenesis by producing protective metabolites that can promote apoptosis of CRC cells.
- Published
- 2021
- Full Text
- View/download PDF